These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 37587813)

  • 1. Therapeutic Approaches for the Treatment of Interstitial Lung Disease: An Exploratory Review on Molecular Mechanisms.
    Amin R; Pandey R; Vaishali K; Acharya V; Sinha MK; Kumar N
    Mini Rev Med Chem; 2024; 24(6):618-633. PubMed ID: 37587813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and management of cough in interstitial lung disease.
    Rasheed AZ; Metersky ML; Ghazal F
    Expert Rev Respir Med; 2023 Dec; 17(12):1177-1190. PubMed ID: 38159067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
    Lamb YN
    Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.
    Makino S
    Mod Rheumatol; 2021 Jan; 31(1):13-19. PubMed ID: 32964766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease.
    Adegunsoye A; Vij R; Noth I
    Chest; 2019 May; 155(5):1026-1040. PubMed ID: 30660786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise-Based Pulmonary Rehabilitation for Interstitial Lung Diseases: A Review of Components, Prescription, Efficacy, and Safety.
    Mendes RG; Castello-Simões V; Trimer R; Garcia-Araújo AS; Gonçalves Da Silva AL; Dixit S; Di Lorenzo VAP; Archiza B; Borghi-Silva A
    Front Rehabil Sci; 2021; 2():744102. PubMed ID: 36188788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases.
    Fischer A; Distler J
    Clin Rheumatol; 2019 Oct; 38(10):2673-2681. PubMed ID: 31423560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of fibrosing interstitial lung disease.
    Wong AW; Ryerson CJ; Guler SA
    Respir Res; 2020 Jan; 21(1):32. PubMed ID: 31996266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary rehabilitation for interstitial lung disease.
    Dowman L; Hill CJ; May A; Holland AE
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD006322. PubMed ID: 34559419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Lung Microbiome in Fibrotic Interstitial Lung Disease-A Systematic Review.
    Puiu R; Motoc NS; Lucaciu S; Ruta MV; Rajnoveanu RM; Todea DA; Man MA
    Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chinese expert consensus on multidisciplinary discussion of interstitial lung disease].
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Dec; 46(12):1176-1188. PubMed ID: 37989522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of fibrotic interstitial lung disease: current approaches and future directions.
    Johannson KA; Chaudhuri N; Adegunsoye A; Wolters PJ
    Lancet; 2021 Oct; 398(10309):1450-1460. PubMed ID: 34499866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial Lung Disease: A Review.
    Maher TM
    JAMA; 2024 May; 331(19):1655-1665. PubMed ID: 38648021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental and quantitative imaging techniques in interstitial lung disease.
    Weatherley ND; Eaden JA; Stewart NJ; Bartholmai BJ; Swift AJ; Bianchi SM; Wild JM
    Thorax; 2019 Jun; 74(6):611-619. PubMed ID: 30886067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances with pharmacotherapy for the treatment of interstitial lung disease.
    Comes A; Sgalla G; Perrotta A; Richeldi L
    Expert Opin Pharmacother; 2022 Mar; 23(4):483-495. PubMed ID: 34907821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers.
    Faverio P; Piluso M; De Giacomi F; Della Zoppa M; Cassandro R; Harari S; Luppi F; Pesci A
    Respiration; 2020; 99(10):838-845. PubMed ID: 33264777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
    Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial.
    Dowman LM; McDonald CF; Hill CJ; Lee AL; Barker K; Boote C; Glaspole I; Goh NSL; Southcott AM; Burge AT; Gillies R; Martin A; Holland AE
    Thorax; 2017 Jul; 72(7):610-619. PubMed ID: 28213592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.